Human Collagen IVα Rat Monoclonal Antibodies Dashboard

Powerful Tools for Collagen IV and Alport Syndrome Research

Anti-Collagen 4 Cocktail mAb (Clones H53, B51, H25)
(Cat. No SGE-CFT45325)

Alport syndrome is an inherited disease characterized by the pathological absence or reduction of the collagen α5(IV) chain in glomerular basement membrane (GBM), tubular basement membrane (TBM) and Bowman's capsular basement membrane. Anti-Collagen 4 Cocktail mAb (Clones H53, B51, H25) is a cocktail of three different rat mAbs for easy and rapid staining of human renal and skin biopsy sections to distinguish Alport syndrome from normal tissue. It comprises two different FITC-conjugated mAbs (clones H53 and B51) that reveal the α5(IV) chain in glomerular, tubular and Bowman's capsular BMs and a Texas Red-conjugated mAb (clone H25) that targets α2(IV) to reveal endothelial basement membrane structure.

Two-color fluorescence image of a normal human kidney section stained with Anti-Collagen 4 Cocktail mAb (Clones H53, B51, H25). FITC fluorescence (α5(IV) chain) is observed in the GBM, part of the TBM and Bowman's capsular BM. BMs where both FITC and Texas Red are present appear orange to yellow.

Two-color fluorescence image of an X-linked Alport syndrome kidney section stained with Anti-Collagen 4 Cocktail mAb (Clones H53, B51, H25). The absence of FITC fluorescence indicates loss of the α5(IV) chain while the maintenance of Texas Red fluorescence targeting the α2(IV) chain highlights endothelial BM structures.


Product and Ordering Information TOP

CosmoBio USA is pleased to offer Anti-Collagen 4 Cocktail mAb (Clones H53, B51, H25) (antibody cocktail): a rapid, easy and reliable method to characterize Alport syndrome patient samples. It replaces a previous complicated, time-consuming and labor-intensive approach that required a denaturation step to reveal epitopes and that employed indirect immunofluorescence staining. Instead, the improved approach employs denaturation-free, two-color direct staining of collagen α5(IV) and α2(IV) chains with fluorochrome-conjugated, epitope-defined rat monoclonal antibodies against collagen triple-helical and NC1 domains. Also sold individually (labeled and unlabeled), these epitope-defined monoclonal antibodies are useful for research on hereditary diseases related to collagen IV.

Human Collagen IVα Rat Monoclonal Antibodies
     Anti-Collagen 4 Cocktail mAb (Clones H53, B51, H25) TOP
Clone
(Click for datasheet)
Label Specificity Size Acid
Treatment
Required
Storage Application Catalog Number
(Click for order information)
H53 FITC α5 1 ml no 4°C dark IF (frozen sections) SGE-CFT45325
B51 FITC α5
H25 Texas Red α2
     Individual Antibodies TOP
Clone
(Click for datasheet)
Label Specificity Size Acid
Treatment
Required
Storage Application Catalog Number
(Click for order information)
H53 FITC α5 0.5 ml no 4°C dark IF (frozen sections) SGE-CFT453
H53 none α5 0.5 ml no -20°C IF (frozen sections) SGE-C453
B51 FITC α5 0.5 ml no 4°C dark IF (frozen sections) SGE-CFT451
B51 none α5 0.5 ml no -20°C IF (frozen sections) SGE-C451
H25 Texas Red α2 0.5 ml no 4°C dark IF (frozen sections) SGE-CFT425
H25 none α2 0.5 ml no -20°C IF (frozen sections) SGE-C425
H52 none α5 0.5 ml yes -20°C WB, IF (frozen sections) SGE-C452

Antibody Specifications TOP

CloneSubclassSpecificityα1α2α3α4α5α6Epitope
Four different anti-human collagen IVα clones
H53 IgG2a,k Imperfection III - - - - + - IDVEF
B51 IgG2a NC1 domain - - - - + - unknown
H25 IgG1,k Imperfection XIII - + - - - - EAIQP
H52 IgG2b,k NCI domain - - - - + - SKPQSETL


References TOP

  1. Kagawa M et al. Back
    Epitope-defined monoclonal antibodies against type-IV collagen for diagnosis of Alport syndrome.
    Nephrol. Dial. Transplant. 12: 1238-1241 (1997) (PMID: 9198058)
  2. Borza DB et al. Back
    The NCI domain of collagen IV encodes a novel network composed of the α1, α2, α5, and α6 chains in smooth muscle basement membranes.
    J. Biol. Chem. 276: 28532-28540 (2001) (PMID: 11375996)
  3. Sado et al. Back
    Establishment by the rat lymph node method of epitope-defined monoclonal antibodies recognizing the six different α chains of human type IV collagen.
    Histochem. Cell Biol. 104: 267-275 (1995) (PMID: 8548560)
  4. Yoshioka K et al.
    Type IV collagen α5 chain: Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody.
    Am. J. Pathol. 144: 986-996 (1994) (PMID: 8178947)
  5. Ninomiya Y et al.
    Differential expression of two basement membrane collagen genes, COL4A6 and COL4A5, demonstrated by immunofluorescence staining using peptide-specific monoclonal antibodies.
    J. Cell Biol. 130: 1219-1229 (1995) (PMID: 7657706)
  6. Naito I et al.
    Relationship between COL4A5 gene mutation and distribution of type IV collagen in male X-linked Alport syndrome.
    Kidney Int. 50: 304-311 (1996) (PMID: 8807602)

Citations TOP

  1. Bu L et al.
    Somatic Mosaicism in a Male Patient With X-linked Alport Syndrome.
    Kidney Int Rep. 14(4): 1031-1035 (2019) (PMID: 31312776)
  2. Samar M et al.
    Negative Staining for COL4A5 Correlates With Worse Prognosis and More Severe Ultrastructural Alterations in Males With Alport Syndrome.
    Kidney Int Rep. 2(1): 44-52 (2017) (PMID: 29142939)
  3. Malone AF et al.
    Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome.
    Pediatr Nephrol. 32(6): 997-1003 (2017) (PMID: 28013382)
  4. Nozu K et al.
    X-linked Alport syndrome caused by splicing mutations in COL4A5.
    Am Soc Nephrol. 9(11): 1958-64 (2014) (PMID: 25183659)
  5. Matsubara S et al.
    Pregnancy complicated with Alport syndrome: a good obstetric outcome and failure to diagnose an infant born to a mother with Alport syndrome by umbilical cord immunofluorescence staining.
    Obstet Gynaecol Res. 35(6): 1109-14 (2009) (PMID: 20144175)
  6. Patey-Mariaud de Serre N et al.
    Collagen alpha5 and alpha2(IV) chain coexpression: analysis of skin biopsies of Alport patients.
    Kidney Int. 72(4): 512-6 (2007) (PMID: 17554254)
  7. Kharrat M et al.
    Autosomal dominant Alport's syndrome: study of a large Tunisian family.
    Kidney Dis Transpl. 17(3): 320-5 (2006) (PMID: 16970251)
TOP